PAPER Riverol M, López OL
SEARCH RESULTS
331122 RESULTS
PAPER Vasconcelos Ld, Jackowski AP, Oliveira MO, Flor YM, Bueno OF, Brucki SM
Voxel-based morphometry findings in Alzheimer's disease: neuropsychiatric symptoms and disability correlations- preliminary results.
Clinics (Sao Paulo). 2011;66(6):1045-50. PubMed: 21808873PAPER Newton W, McManus A
Consumption of fish and Alzheimer's disease.
J Nutr Health Aging. 2011 Aug;15(7):551-4552. PubMed: 21808933PAPER Harciarek M, Kertesz A
Primary progressive aphasias and their contribution to the contemporary knowledge about the brain-language relationship.
Neuropsychol Rev. 2011 Sep;21(3):271-87. PubMed: 21809067PAPER Hayden KM, Welsh-Bohmer KA
Epidemiology of Cognitive Aging and Alzheimer's Disease: Contributions of the Cache County Utah Study of Memory, Health and Aging.
Curr Top Behav Neurosci. 2011 Aug 2; PubMed: 21809193PAPER Kotyczka C, Boettler U, Lang R, Stiebitz H, Bytof G, Lantz I, Hofmann T, Marko D, Somoza V
Dark roast coffee is more effective than light roast coffee in reducing body weight, and in restoring red blood cell vitamin E and glutathione concentrations in healthy volunteers.
Mol Nutr Food Res. 2011 Oct;55(10):1582-6. PubMed: 21809439PAPER Riera J, Hatanaka R, Uchida T, Ozaki T, Kawashima R
Quantifying the uncertainty of spontaneous Ca2+ oscillations in astrocytes: particulars of Alzheimer's disease.
Biophys J. 2011 Aug 3;101(3):554-64. PubMed: 21806923PAPER Arnaud L, Chen S, Liu F, Li B, Khatoon S, Grundke-Iqbal I, Iqbal K
Mechanism of inhibition of PP2A activity and abnormal hyperphosphorylation of tau by I2(PP2A)/SET.
FEBS Lett. 2011 Sep 2;585(17):2653-9. PubMed: 21806989PAPER Bromley-Brits K, Deng Y, Song W
Morris water maze test for learning and memory deficits in Alzheimer's disease model mice.
J Vis Exp. 2011;(53) PubMed: 21808223PAPER Pasinetti GM, Wang J, Porter S, Ho L
Caloric intake, dietary lifestyles, macronutrient composition, and alzheimer' disease dementia.
Int J Alzheimers Dis. 2011;2011:806293. PubMed: 21808725PAPER Ohta E, Takiyama Y
MRI findings in neuroferritinopathy.
Neurol Res Int. 2012;2012:197438. PubMed: 21808735PAPER Andrieu S, Aboderin I, Baeyens JP, Beard J, Benetos A, Berrut G, Brainin M, Cha HB, Chen LK, Du P, Forette B, Forette F, Franco A, Fratiglioni L, Gillette-Guyonnet S, Gold G, Gomez F, Guimaraes R, Gustafson D, Khachaturian A, Luchsinger J, Mangialasche F, Mathiex-Fortunet H, Michel JP, Richard E, Schneider LS, Solomon A, Vellas B
IAGG workshop: health promotion program on prevention of late onset dementia.
J Nutr Health Aging. 2011 Aug;15(7):562-75. PubMed: 21808935SWAMYNATHAN GANESAN
UNIVERSITY OF ADELAIDEADELAIDE, Australia
Lennart Mucke on Ablation of cellular prion protein does not ameliorate abnormal neural network activity or cognitive dysfunction in the J20 line of human amyloid precursor protein transgenic mice.
COMMENT I fully understand and share Dr. Strittmatter’s eagerness to resolve the controversy surrounding his original findings. As pointed out in our paper, the different effects of PrPC ablation on Aβ-induced functional deficits observed by different investigato
Stephen Strittmatter on Ablation of cellular prion protein does not ameliorate abnormal neural network activity or cognitive dysfunction in the J20 line of human amyloid precursor protein transgenic mice.
COMMENT A growing body of literature supports a key role of cellular prion protein (PrPc) in Alzheimer's pathophysiology. Recent reports have demonstrated that endogenous Aβ oligomers from both mouse and human AD brain bind PrPc, and that PrPc is required fo